- Ozempic (semaglutide) was developed for type 2 diabetes management and works as a GLP-1 receptor agonist.
- It reduces appetite and slows stomach emptying, which is why people eat less and lose weight.
- Side effects range from nausea and constipation to gallbladder problems, and pancreatitis is a listed warning.
- In the STEP 1 extension, people regained about two-thirds of the weight they had lost within a year of stopping.
- Ayurveda sees weight as a matter of digestion, activity and habits; any medicine decision belongs with your treating doctor.
"Doctor, should I just take that injection everyone is talking about?" Few questions come up in clinic as often these days, from people with diabetes, from young women struggling with PCOS weight, and from people who simply want to look slimmer for a wedding.
Here is the honest answer: Ozempic (semaglutide) can cause meaningful weight loss, but it is not a magic drug. It was developed for type 2 diabetes management, it has real side effects, and much of the weight tends to come back after stopping. Long-term weight control still depends on how you eat, move and sleep. This post is based on a short video by Dr. Aditya Kunal on this exact question, expanded with the trial data.
What Ozempic is, in plain words
As Dr. Aditya Kunal says in his video, the first thing to understand is that Ozempic was not developed as a weight loss treatment. It was developed to help manage type 2 diabetes. Weight loss turned out to be a strong effect, and later the same molecule, semaglutide, was tested at a higher dose specifically for obesity.
Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases after a meal. It tells the pancreas to release insulin when sugar is high, slows how fast the stomach empties and signals the brain that you are full. A GLP-1 drug copies this signal and makes it last much longer.
The result, in his words, is that "it makes you think you are fuller and you don't feel hungry." You eat less, so you lose weight. The weight loss works through a metabolic and appetite pathway, not by melting fat.
How much weight do people actually lose?
The key trial for weight loss is STEP 1, published in the New England Journal of Medicine in 2021. It included 1,961 adults with obesity, or overweight with at least one weight-related condition, who did not have diabetes. They received a weekly 2.4 mg injection of semaglutide or placebo for 68 weeks, both groups with lifestyle counselling.
| Outcome at 68 weeks | Semaglutide | Placebo |
|---|---|---|
| Average change in body weight | About minus 14.9 percent | About minus 2.4 percent |
| Lost 5 percent or more | 86.4 percent of people | 31.5 percent of people |
| Lost 15 percent or more | 50.5 percent of people | 4.9 percent of people |
These are impressive numbers, and it would be dishonest to pretend the drug does not work. The real questions are what it costs your body along the way, and what happens when you stop.
The side effects nobody puts on the poster
Dr. Aditya Kunal lists them directly in his video: nausea, effects on gastric motility, gallbladder disease, pancreatic problems, dehydration and kidney issues. The trial data supports this list.
- Digestive effects are the most common. A 2025 meta-analysis of 13 randomised trials with nearly 27,000 people without diabetes found overall gastrointestinal adverse events were clearly more frequent with semaglutide than placebo. Nausea, vomiting, diarrhoea and constipation lead the list. Most cases were mild, but some people stop the drug because of them.
- Gallbladder problems. The same analysis found semaglutide raised gallbladder disorders, especially gallstones, by more than two and a half times compared with placebo. Rapid weight loss itself is a known trigger for gallstones.
- Pancreatitis is listed as a warning in the prescribing information, even though it is uncommon.
- Dehydration and kidney strain can follow repeated vomiting or diarrhoea.
- Loss of muscle along with fat is a concern with any rapid weight loss, especially if protein intake and strength training are poor.
In Ayurvedic terms, a drug that suppresses appetite for months also changes how your agni (digestive fire) behaves. Some patients describe heaviness, bloating and constipation, which fit a picture of slowed digestion. That is a reason for supervision, not panic.
What happens when you stop
This is the part Dr. Aditya Kunal calls "the most interesting fact", and he is right. A planned extension of STEP 1, published in Diabetes, Obesity and Metabolism in 2022, followed 327 participants for one year after stopping the injections.
People on semaglutide had lost an average of 17.3 percent of body weight by week 68. One year after stopping, they had regained 11.6 percentage points of it. In other words, roughly two-thirds of the lost weight came back. Improvements in blood pressure, blood sugar and other markers also moved back toward where they started.
The authors' interpretation is that obesity behaves like a chronic condition: when treatment is withdrawn, the body tends to return to its earlier state. Dr. Aditya Kunal's interpretation is more practical: do not rely on a drug alone for weight management. Change your lifestyle and your dietary pattern.
An Ayurvedic reading of weight and appetite
Ayurveda describes excess weight under the name sthaulya or medoroga, a disorder of meda dhatu (fat tissue) driven by kapha and a disturbed metabolism. The classical causes are familiar: overeating, heavy and sweet food, day sleep, lack of exercise and a sedentary life. We explain this in detail in sthaulya: how Ayurveda approaches weight gain.
What interests me as an Ayurvedic doctor is that GLP-1 drugs force several things the classical texts recommend: eating less, eating slowly, feeling full sooner and avoiding heavy meals. The difference is that the drug imposes these from outside. When it is removed, the habits often have not changed, so the weight returns.
Ayurveda's goal is to build those habits from inside:
- Eat only when the last meal is digested. Real hunger, not boredom or the clock.
- Keep dinner light and early. A heavy late meal is one of the strongest kapha-building habits.
- Prefer light, dry, warm foods such as millets, barley, moong dal and vegetables over heavy, sweet, oily ones.
- Move daily. The texts prescribe vyayama (exercise) to half of one's capacity, until light sweating and breathlessness.
- Avoid day sleep unless you are unwell, elderly or advised otherwise.
- Therapies like udvartana, a dry powder massage, are used in clinics as supportive care, not as fat burners.
If you are already on semaglutide
This post is not an argument against your prescription. If your doctor has started you on semaglutide or a similar drug, especially for diabetes or for obesity with complications, it may be the right choice for you. Please do not stop it, skip doses or reduce it because of something you read online, including this article. Discuss any concern with the doctor who prescribed it.
What you can do is use the months on the medicine well:
- Eat enough protein at every meal: dal, paneer, curd, eggs, fish or chicken as per your diet.
- Start strength training to protect muscle.
- Learn portion sizes while your appetite is low, so they feel normal later.
- Drink enough water, especially if you have vomiting or diarrhoea.
- Report persistent abdominal pain, severe vomiting or yellowing of the eyes to your doctor immediately.
Tell your doctor too if you plan to add any Ayurvedic medicine. Some herbs also lower blood sugar, and combining them without supervision can cause low sugar in people with diabetes.
Five questions to ask before you start any weight loss drug
Whether the suggestion comes from a friend, a gym trainer or an online pharmacy, these are the questions worth asking your doctor first:
- Do I actually meet the criteria? These drugs are studied in people with obesity, or overweight with conditions such as diabetes, high blood pressure or sleep apnoea. Wanting to lose a few kilos before an event is a different situation.
- What is my plan for after? Ask how long you are expected to take it and what happens when you stop, given the regain seen in trials.
- Do I have a history of gallstones, pancreatitis or thyroid problems? These change the risk picture, and your doctor needs to know.
- Is the product genuine? Injections bought without prescription from unverified sellers carry the risk of fakes and wrong doses.
- Who will monitor me? Regular follow-up for side effects, blood sugar and weight is part of safe use.
Equally, if someone offers you an "Ayurvedic Ozempic" or a herbal powder that promises the same weight loss, apply the same scepticism. Genuine Ayurvedic treatment begins with an assessment of your prakriti, digestion and history, not with a miracle claim on a label. Our guide on how to spot genuine Ayurvedic medicine explains what to check.
Why India needs to get this right
The ICMR-INDIAB study found generalised obesity in 28.6 percent and abdominal obesity in 39.5 percent of Indian adults. Globally, the World Health Organization estimates that about one in seven people were living with obesity in 2024. WHO now includes GLP-1 medicines as one component of obesity care, alongside nutrition, activity, behaviour and other support. That word "component" matters. No serious guideline treats an injection as the whole answer.
Indians also tend to carry fat around the abdomen and develop diabetes at lower body weights than many other groups. That makes daily habits, which cost nothing and work for life, the foundation for most families. Prediabetes is a particularly good window to act, as we explain in prediabetes and insulin resistance.
A plan that does not end when the prescription does
If you are weighing up weight loss drugs, or you are on one and worried about what comes after, it helps to sit down with someone who will look at your reports, your routine and your digestion together. Dr. Aditya Kunal sees patients for weight and metabolic concerns in Patna and online; you can start with a 30 minute online consultation or read more on the weight management page. The aim is simple: a weight you can keep without depending on any single drug for life.
Frequently asked questions
Is Ozempic safe for weight loss?
Semaglutide has been studied in large trials and is approved in some countries, under brand names and doses specific to weight management, for people with obesity or overweight with related conditions. It has known side effects and is a prescription medicine that needs medical supervision. It is not a cosmetic shortcut for a few extra kilos.
Will I gain weight back after stopping Ozempic?
Many people do. In the STEP 1 trial extension, participants who stopped semaglutide regained around two-thirds of the weight they had lost within one year, and most metabolic improvements drifted back toward baseline.
Can Ayurveda replace Ozempic?
No Ayurvedic medicine should be presented as a replacement for a prescribed drug. Ayurveda can support weight management through diet, routine, activity and individualised treatment. If you are on semaglutide, keep taking it as prescribed and discuss any changes with the doctor who prescribed it.
What are the common side effects of semaglutide?
Nausea, vomiting, diarrhoea, constipation and stomach discomfort are the most common. Gallstones and gallbladder problems are more frequent than with placebo, and pancreatitis is a listed warning. Dehydration from vomiting or diarrhoea can strain the kidneys.
Should I take Ozempic if I am not diabetic and only want to lose 5 kg?
That is a question for a qualified doctor who knows your full history. Most guidelines reserve these drugs for people with obesity or overweight with weight-related health problems, alongside diet and activity changes.
Sources and further reading
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med, 2021
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: STEP 1 trial extension. Diabetes Obes Metab, 2022
- Gastrointestinal safety of semaglutide and tirzepatide vs placebo in obese individuals without diabetes: systematic review and meta-analysis. Ann Saudi Med, 2025
- World Health Organization. Obesity and overweight fact sheet
- Anjana RM et al. Metabolic non-communicable disease health report of India: ICMR-INDIAB-17. Lancet Diabetes Endocrinol, 2023

